nodes	percent_of_prediction	percent_of_DWPC	metapath
Minocycline—SLC22A11—Methotrexate—germ cell cancer	0.117	0.34	CbGbCtD
Minocycline—SLC22A7—Methotrexate—germ cell cancer	0.111	0.324	CbGbCtD
Minocycline—SLC22A8—Methotrexate—germ cell cancer	0.068	0.198	CbGbCtD
Minocycline—SLC22A6—Methotrexate—germ cell cancer	0.0474	0.138	CbGbCtD
Minocycline—CYCS—adrenal medulla—germ cell cancer	0.0267	0.0694	CbGeAlD
Minocycline—CASP3—adrenal medulla—germ cell cancer	0.0229	0.0595	CbGeAlD
Minocycline—CASP3—cochlea—germ cell cancer	0.0143	0.0372	CbGeAlD
Minocycline—IL1B—dermis—germ cell cancer	0.0128	0.0334	CbGeAlD
Minocycline—SLC22A8—choroid plexus—germ cell cancer	0.0111	0.0289	CbGeAlD
Minocycline—MMP9—dermis—germ cell cancer	0.0107	0.0278	CbGeAlD
Minocycline—CYCS—pineal body—germ cell cancer	0.00925	0.024	CbGeAlD
Minocycline—CASP3—appendage—germ cell cancer	0.00812	0.0211	CbGeAlD
Minocycline—CASP3—skin epidermis—germ cell cancer	0.00676	0.0176	CbGeAlD
Minocycline—CYCS—ganglion—germ cell cancer	0.00664	0.0173	CbGeAlD
Minocycline—IL1B—appendage—germ cell cancer	0.00649	0.0169	CbGeAlD
Minocycline—CASP3—ganglion—germ cell cancer	0.00569	0.0148	CbGeAlD
Minocycline—MMP9—appendage—germ cell cancer	0.00541	0.0141	CbGeAlD
Minocycline—IL1B—skin epidermis—germ cell cancer	0.0054	0.014	CbGeAlD
Minocycline—CYCS—blood vessel—germ cell cancer	0.00528	0.0137	CbGeAlD
Minocycline—CASP3—endothelium—germ cell cancer	0.0049	0.0127	CbGeAlD
Minocycline—CASP3—blood vessel—germ cell cancer	0.00452	0.0118	CbGeAlD
Minocycline—MMP9—skin epidermis—germ cell cancer	0.0045	0.0117	CbGeAlD
Minocycline—SLC22A8—optic choroid—germ cell cancer	0.00426	0.0111	CbGeAlD
Minocycline—IL1B—endothelium—germ cell cancer	0.00392	0.0102	CbGeAlD
Minocycline—CYCS—neck—germ cell cancer	0.00378	0.00981	CbGeAlD
Minocycline—IL1B—blood vessel—germ cell cancer	0.00361	0.00939	CbGeAlD
Minocycline—CASP1—trigeminal ganglion—germ cell cancer	0.00339	0.0088	CbGeAlD
Minocycline—MMP9—endothelium—germ cell cancer	0.00326	0.00848	CbGeAlD
Minocycline—CASP3—neck—germ cell cancer	0.00324	0.00841	CbGeAlD
Minocycline—CYCS—embryo—germ cell cancer	0.00315	0.00818	CbGeAlD
Minocycline—MMP9—blood vessel—germ cell cancer	0.00301	0.00782	CbGeAlD
Minocycline—SLC22A8—urine—germ cell cancer	0.00297	0.00772	CbGeAlD
Minocycline—CYCS—brainstem—germ cell cancer	0.00289	0.0075	CbGeAlD
Minocycline—CYCS—eye—germ cell cancer	0.00281	0.0073	CbGeAlD
Minocycline—CYCS—retina—germ cell cancer	0.00278	0.00724	CbGeAlD
Minocycline—CASP3—embryo—germ cell cancer	0.0027	0.00701	CbGeAlD
Minocycline—CYCS—telencephalon—germ cell cancer	0.00256	0.00666	CbGeAlD
Minocycline—CASP1—skin of body—germ cell cancer	0.00254	0.0066	CbGeAlD
Minocycline—CASP1—decidua—germ cell cancer	0.00252	0.00655	CbGeAlD
Minocycline—CASP3—brainstem—germ cell cancer	0.00247	0.00642	CbGeAlD
Minocycline—CYCS—skin of body—germ cell cancer	0.00244	0.00635	CbGeAlD
Minocycline—CASP3—eye—germ cell cancer	0.00241	0.00625	CbGeAlD
Minocycline—CASP3—retina—germ cell cancer	0.00238	0.0062	CbGeAlD
Minocycline—IL1B—trigeminal ganglion—germ cell cancer	0.00223	0.0058	CbGeAlD
Minocycline—CASP1—gonad—germ cell cancer	0.00222	0.00577	CbGeAlD
Minocycline—CASP1—uterus—germ cell cancer	0.00221	0.00573	CbGeAlD
Minocycline—VEGFA—trigeminal ganglion—germ cell cancer	0.00219	0.0057	CbGeAlD
Minocycline—CASP3—telencephalon—germ cell cancer	0.00219	0.0057	CbGeAlD
Minocycline—CASP1—pituitary gland—germ cell cancer	0.00217	0.00563	CbGeAlD
Minocycline—CASP3—Syndecan-2-mediated signaling events—FGFR3—germ cell cancer	0.00216	0.00796	CbGpPWpGaD
Minocycline—IL1B—embryo—germ cell cancer	0.00215	0.0056	CbGeAlD
Minocycline—MMP9—neck—germ cell cancer	0.00215	0.0056	CbGeAlD
Minocycline—CYCS—gonad—germ cell cancer	0.00214	0.00555	CbGeAlD
Minocycline—CYCS—uterus—germ cell cancer	0.00212	0.00552	CbGeAlD
Minocycline—CASP3—skin of body—germ cell cancer	0.00209	0.00544	CbGeAlD
Minocycline—CASP3—decidua—germ cell cancer	0.00208	0.0054	CbGeAlD
Minocycline—MMP9—Endochondral Ossification—ALPL—germ cell cancer	0.00205	0.00754	CbGpPWpGaD
Minocycline—MMP9—AGE/RAGE pathway—ALPL—germ cell cancer	0.002	0.00736	CbGpPWpGaD
Minocycline—CYCS—The citric acid (TCA) cycle and respiratory electron transport—CRABP1—germ cell cancer	0.00199	0.00733	CbGpPWpGaD
Minocycline—IL1B—brainstem—germ cell cancer	0.00197	0.00513	CbGeAlD
Minocycline—CASP1—adrenal gland—germ cell cancer	0.00194	0.00503	CbGeAlD
Minocycline—IL1B—eye—germ cell cancer	0.00192	0.005	CbGeAlD
Minocycline—CASP1—midbrain—germ cell cancer	0.00191	0.00497	CbGeAlD
Minocycline—VEGFA—Platelet degranulation—CD9—germ cell cancer	0.0019	0.00701	CbGpPWpGaD
Minocycline—CASP1—bone marrow—germ cell cancer	0.00187	0.00487	CbGeAlD
Minocycline—CASP1—spinal cord—germ cell cancer	0.00186	0.00484	CbGeAlD
Minocycline—CYCS—adrenal gland—germ cell cancer	0.00186	0.00484	CbGeAlD
Minocycline—CYCS—midbrain—germ cell cancer	0.00184	0.00478	CbGeAlD
Minocycline—CASP3—gonad—germ cell cancer	0.00183	0.00476	CbGeAlD
Minocycline—CASP3—uterus—germ cell cancer	0.00182	0.00473	CbGeAlD
Minocycline—VEGFA—Response to elevated platelet cytosolic Ca2+—CD9—germ cell cancer	0.00181	0.00668	CbGpPWpGaD
Minocycline—CASP1—female gonad—germ cell cancer	0.0018	0.00469	CbGeAlD
Minocycline—CYCS—bone marrow—germ cell cancer	0.0018	0.00468	CbGeAlD
Minocycline—MMP9—embryo—germ cell cancer	0.0018	0.00467	CbGeAlD
Minocycline—CYCS—spinal cord—germ cell cancer	0.00179	0.00466	CbGeAlD
Minocycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00179	0.0066	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—PHC1—germ cell cancer	0.00179	0.00659	CbGpPWpGaD
Minocycline—CASP3—pituitary gland—germ cell cancer	0.00179	0.00464	CbGeAlD
Minocycline—VEGFA—Endochondral Ossification—ALPL—germ cell cancer	0.00178	0.00654	CbGpPWpGaD
Minocycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00177	0.00651	CbGpPWpGaD
Minocycline—IL1B—telencephalon—germ cell cancer	0.00175	0.00455	CbGeAlD
Minocycline—CYCS—female gonad—germ cell cancer	0.00174	0.00451	CbGeAlD
Minocycline—VEGFA—telencephalon—germ cell cancer	0.00172	0.00448	CbGeAlD
Minocycline—CASP3—medulla oblongata—germ cell cancer	0.00172	0.00448	CbGeAlD
Minocycline—VEGFA—Differentiation Pathway—FGF4—germ cell cancer	0.00169	0.00624	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—NANOG—germ cell cancer	0.00168	0.0062	CbGpPWpGaD
Minocycline—CASP1—endocrine gland—germ cell cancer	0.00168	0.00436	CbGeAlD
Minocycline—IL1B—skin of body—germ cell cancer	0.00167	0.00435	CbGeAlD
Minocycline—IL1B—decidua—germ cell cancer	0.00166	0.00432	CbGeAlD
Minocycline—CASP1—head—germ cell cancer	0.00166	0.00431	CbGeAlD
Minocycline—VEGFA—decidua—germ cell cancer	0.00163	0.00425	CbGeAlD
Minocycline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00163	0.00599	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—POU5F1—germ cell cancer	0.00162	0.00597	CbGpPWpGaD
Minocycline—CYCS—endocrine gland—germ cell cancer	0.00162	0.0042	CbGeAlD
Minocycline—MMP9—eye—germ cell cancer	0.0016	0.00416	CbGeAlD
Minocycline—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.0016	0.0059	CbGpPWpGaD
Minocycline—CASP1—testis—germ cell cancer	0.0016	0.00416	CbGeAlD
Minocycline—CASP3—adrenal gland—germ cell cancer	0.0016	0.00415	CbGeAlD
Minocycline—CYCS—head—germ cell cancer	0.00159	0.00414	CbGeAlD
Minocycline—CASP3—bone marrow—germ cell cancer	0.00154	0.00401	CbGeAlD
Minocycline—CYCS—testis—germ cell cancer	0.00154	0.004	CbGeAlD
Minocycline—CASP3—BDNF signaling pathway—ALPL—germ cell cancer	0.00154	0.00568	CbGpPWpGaD
Minocycline—CASP3—spinal cord—germ cell cancer	0.00154	0.00399	CbGeAlD
Minocycline—CASP1—MAPK Signaling Pathway—FGF4—germ cell cancer	0.00149	0.00551	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00149	0.0055	CbGpPWpGaD
Minocycline—CASP3—female gonad—germ cell cancer	0.00149	0.00387	CbGeAlD
Minocycline—CASP1—cerebellum—germ cell cancer	0.00148	0.00384	CbGeAlD
Minocycline—VEGFA—Bladder Cancer—FGFR3—germ cell cancer	0.00147	0.00541	CbGpPWpGaD
Minocycline—IL1B—uterus—germ cell cancer	0.00145	0.00378	CbGeAlD
Minocycline—MMP9—Syndecan-1-mediated signaling events—FGFR3—germ cell cancer	0.00144	0.00529	CbGpPWpGaD
Minocycline—VEGFA—uterus—germ cell cancer	0.00143	0.00371	CbGeAlD
Minocycline—IL1B—pituitary gland—germ cell cancer	0.00143	0.00371	CbGeAlD
Minocycline—CYCS—cerebellum—germ cell cancer	0.00142	0.0037	CbGeAlD
Minocycline—VEGFA—pituitary gland—germ cell cancer	0.0014	0.00365	CbGeAlD
Minocycline—MMP9—skin of body—germ cell cancer	0.00139	0.00362	CbGeAlD
Minocycline—VEGFA—Differentiation Pathway—KITLG—germ cell cancer	0.00139	0.00513	CbGpPWpGaD
Minocycline—MMP9—decidua—germ cell cancer	0.00138	0.0036	CbGeAlD
Minocycline—CASP3—endocrine gland—germ cell cancer	0.00138	0.0036	CbGeAlD
Minocycline—IL1B—medulla oblongata—germ cell cancer	0.00138	0.00358	CbGeAlD
Minocycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00137	0.00504	CbGpPWpGaD
Minocycline—CASP3—head—germ cell cancer	0.00137	0.00355	CbGeAlD
Minocycline—IL1B—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.00135	0.00498	CbGpPWpGaD
Minocycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00135	0.00496	CbGpPWpGaD
Minocycline—CASP3—testis—germ cell cancer	0.00132	0.00343	CbGeAlD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—FGF4—germ cell cancer	0.0013	0.00478	CbGpPWpGaD
Minocycline—IL1B—adrenal gland—germ cell cancer	0.00127	0.00331	CbGeAlD
Minocycline—IL1B—midbrain—germ cell cancer	0.00126	0.00327	CbGeAlD
Minocycline—VEGFA—adrenal gland—germ cell cancer	0.00125	0.00326	CbGeAlD
Minocycline—CASP1—Amyotrophic lateral sclerosis (ALS)—TP53—germ cell cancer	0.00124	0.00458	CbGpPWpGaD
Minocycline—IL1B—bone marrow—germ cell cancer	0.00123	0.0032	CbGeAlD
Minocycline—IL1B—spinal cord—germ cell cancer	0.00123	0.00319	CbGeAlD
Minocycline—CYCS—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.00122	0.00449	CbGpPWpGaD
Minocycline—CASP3—cerebellum—germ cell cancer	0.00122	0.00317	CbGeAlD
Minocycline—VEGFA—bone marrow—germ cell cancer	0.00121	0.00315	CbGeAlD
Minocycline—MMP9—uterus—germ cell cancer	0.00121	0.00315	CbGeAlD
Minocycline—VEGFA—spinal cord—germ cell cancer	0.00121	0.00314	CbGeAlD
Minocycline—CASP1—brain—germ cell cancer	0.0012	0.00312	CbGeAlD
Minocycline—IL1B—female gonad—germ cell cancer	0.00119	0.00309	CbGeAlD
Minocycline—VEGFA—female gonad—germ cell cancer	0.00117	0.00304	CbGeAlD
Minocycline—IL1B—Myometrial Relaxation and Contraction Pathways—OXT—germ cell cancer	0.00117	0.0043	CbGpPWpGaD
Minocycline—CASP1—lymph node—germ cell cancer	0.00116	0.00301	CbGeAlD
Minocycline—CYCS—brain—germ cell cancer	0.00116	0.003	CbGeAlD
Minocycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A3—germ cell cancer	0.00114	0.0042	CbGpPWpGaD
Minocycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A3—germ cell cancer	0.00112	0.00414	CbGpPWpGaD
Minocycline—CYCS—lymph node—germ cell cancer	0.00112	0.0029	CbGeAlD
Minocycline—IL1B—endocrine gland—germ cell cancer	0.00111	0.00287	CbGeAlD
Minocycline—ALOX5—decidua—germ cell cancer	0.00109	0.00284	CbGeAlD
Minocycline—IL1B—head—germ cell cancer	0.00109	0.00284	CbGeAlD
Minocycline—MMP9—FGF signaling pathway—FGFR3—germ cell cancer	0.00108	0.004	CbGpPWpGaD
Minocycline—CYCS—Ceramide signaling pathway—MYC—germ cell cancer	0.00107	0.00396	CbGpPWpGaD
Minocycline—CYCS—Intrinsic Pathway for Apoptosis—TP53—germ cell cancer	0.00106	0.00392	CbGpPWpGaD
Minocycline—MMP9—adrenal gland—germ cell cancer	0.00106	0.00276	CbGeAlD
Minocycline—IL1B—testis—germ cell cancer	0.00105	0.00274	CbGeAlD
Minocycline—VEGFA—testis—germ cell cancer	0.00104	0.00269	CbGeAlD
Minocycline—CASP3—MAPK Signaling Pathway—FGF4—germ cell cancer	0.00103	0.0038	CbGpPWpGaD
Minocycline—MMP9—bone marrow—germ cell cancer	0.00103	0.00267	CbGeAlD
Minocycline—MMP9—spinal cord—germ cell cancer	0.00102	0.00266	CbGeAlD
Minocycline—SLC22A8—trigeminal ganglion—germ cell cancer	0.000995	0.00258	CbGeAlD
Minocycline—MMP9—female gonad—germ cell cancer	0.000991	0.00257	CbGeAlD
Minocycline—CASP3—brain—germ cell cancer	0.00099	0.00257	CbGeAlD
Minocycline—VEGFA—cerebellum—germ cell cancer	0.000958	0.00249	CbGeAlD
Minocycline—CASP3—lymph node—germ cell cancer	0.000957	0.00249	CbGeAlD
Minocycline—VEGFA—Differentiation Pathway—KIT—germ cell cancer	0.00095	0.0035	CbGpPWpGaD
Minocycline—MMP9—Endochondral Ossification—FGFR3—germ cell cancer	0.000947	0.00349	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—TDGF1—germ cell cancer	0.000946	0.00349	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—FGF4—germ cell cancer	0.000934	0.00344	CbGpPWpGaD
Minocycline—CASP3—Integrated Cancer Pathway—MYC—germ cell cancer	0.00093	0.00343	CbGpPWpGaD
Minocycline—MMP9—endocrine gland—germ cell cancer	0.000921	0.00239	CbGeAlD
Minocycline—MMP9—head—germ cell cancer	0.000909	0.00236	CbGeAlD
Minocycline—VEGFA—SIDS Susceptibility Pathways—SOX2—germ cell cancer	0.000899	0.00331	CbGpPWpGaD
Minocycline—CASP3—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000879	0.00324	CbGpPWpGaD
Minocycline—MMP9—testis—germ cell cancer	0.000879	0.00228	CbGeAlD
Minocycline—SLC22A11—endocrine gland—germ cell cancer	0.000873	0.00227	CbGeAlD
Minocycline—CASP3—Intrinsic Pathway for Apoptosis—TP53—germ cell cancer	0.000859	0.00316	CbGpPWpGaD
Minocycline—CASP3—Amyotrophic lateral sclerosis (ALS)—TP53—germ cell cancer	0.000859	0.00316	CbGpPWpGaD
Minocycline—CASP3—Syndecan-2-mediated signaling events—HRAS—germ cell cancer	0.000857	0.00316	CbGpPWpGaD
Minocycline—SLC22A8—eye—germ cell cancer	0.000857	0.00223	CbGeAlD
Minocycline—SLC22A7—endocrine gland—germ cell cancer	0.000852	0.00222	CbGeAlD
Minocycline—VEGFA—Platelet activation, signaling and aggregation—CD9—germ cell cancer	0.000844	0.00311	CbGpPWpGaD
Minocycline—ALOX5—adrenal gland—germ cell cancer	0.00084	0.00218	CbGeAlD
Minocycline—MMP9—Signaling by SCF-KIT—FGF4—germ cell cancer	0.000824	0.00304	CbGpPWpGaD
Minocycline—VEGFA—Endochondral Ossification—FGFR3—germ cell cancer	0.000822	0.00303	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—TDGF1—germ cell cancer	0.000821	0.00303	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000814	0.003	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—MYC—germ cell cancer	0.000813	0.003	CbGpPWpGaD
Minocycline—SLC22A7—testis—germ cell cancer	0.000813	0.00211	CbGeAlD
Minocycline—ALOX5—bone marrow—germ cell cancer	0.000813	0.00211	CbGeAlD
Minocycline—MMP9—Developmental Biology—SALL4—germ cell cancer	0.000804	0.00296	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—MYC—germ cell cancer	0.000803	0.00296	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000802	0.00296	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000798	0.00294	CbGpPWpGaD
Minocycline—IL1B—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.000796	0.00293	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—H2AFZ—germ cell cancer	0.000796	0.00293	CbGpPWpGaD
Minocycline—IL1B—brain—germ cell cancer	0.000791	0.00206	CbGeAlD
Minocycline—CYCS—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000786	0.0029	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—MYC—germ cell cancer	0.000786	0.0029	CbGpPWpGaD
Minocycline—ALOX5—female gonad—germ cell cancer	0.000783	0.00204	CbGeAlD
Minocycline—VEGFA—brain—germ cell cancer	0.000778	0.00202	CbGeAlD
Minocycline—MMP9—Developmental Biology—NANOG—germ cell cancer	0.000771	0.00284	CbGpPWpGaD
Minocycline—IL1B—lymph node—germ cell cancer	0.000764	0.00199	CbGeAlD
Minocycline—CASP3—Integrated Cancer Pathway—TP53—germ cell cancer	0.000764	0.00281	CbGpPWpGaD
Minocycline—VEGFA—lymph node—germ cell cancer	0.000752	0.00195	CbGeAlD
Minocycline—MMP9—Developmental Biology—POU5F1—germ cell cancer	0.000742	0.00274	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—MYC—germ cell cancer	0.000741	0.00273	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000739	0.00272	CbGpPWpGaD
Minocycline—ALOX5—endocrine gland—germ cell cancer	0.000728	0.00189	CbGeAlD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000728	0.00268	CbGpPWpGaD
Minocycline—ALOX5—head—germ cell cancer	0.000719	0.00187	CbGeAlD
Minocycline—VEGFA—Developmental Biology—SALL4—germ cell cancer	0.000698	0.00257	CbGpPWpGaD
Minocycline—ALOX5—testis—germ cell cancer	0.000695	0.00181	CbGeAlD
Minocycline—CYCS—Apoptosis—MYC—germ cell cancer	0.000687	0.00253	CbGpPWpGaD
Minocycline—CASP3—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—germ cell cancer	0.000681	0.00251	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KITLG—germ cell cancer	0.000677	0.0025	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGF4—germ cell cancer	0.000674	0.00248	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—NANOG—germ cell cancer	0.00067	0.00247	CbGpPWpGaD
Minocycline—CASP3—Copper homeostasis—TP53—germ cell cancer	0.000668	0.00246	CbGpPWpGaD
Minocycline—CYCS—DNA Damage Response—TP53—germ cell cancer	0.000668	0.00246	CbGpPWpGaD
Minocycline—CYCS—p75(NTR)-mediated signaling—TP53—germ cell cancer	0.00066	0.00243	CbGpPWpGaD
Minocycline—CASP1—Apoptosis—TP53—germ cell cancer	0.000659	0.00243	CbGpPWpGaD
Minocycline—MMP9—brain—germ cell cancer	0.000659	0.00171	CbGeAlD
Minocycline—CASP3—DNA Damage Response—MYC—germ cell cancer	0.000656	0.00242	CbGpPWpGaD
Minocycline—CYCS—mTOR signaling pathway—HRAS—germ cell cancer	0.000654	0.00241	CbGpPWpGaD
Minocycline—CYCS—miRNA Regulation of DNA Damage Response—TP53—germ cell cancer	0.000645	0.00238	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—POU5F1—germ cell cancer	0.000645	0.00238	CbGpPWpGaD
Minocycline—ALOX5—cerebellum—germ cell cancer	0.000641	0.00167	CbGeAlD
Minocycline—MMP9—lymph node—germ cell cancer	0.000637	0.00165	CbGeAlD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—MYC—germ cell cancer	0.000634	0.00234	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000633	0.00233	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000621	0.00229	CbGpPWpGaD
Minocycline—CASP1—Apoptosis Modulation and Signaling—TP53—germ cell cancer	0.000618	0.00228	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000612	0.00225	CbGpPWpGaD
Minocycline—SLC22A7—brain—germ cell cancer	0.00061	0.00158	CbGeAlD
Minocycline—VEGFA—Bladder Cancer—TP53—germ cell cancer	0.000609	0.00224	CbGpPWpGaD
Minocycline—CYCS—Alzheimers Disease—TP53—germ cell cancer	0.000592	0.00218	CbGpPWpGaD
Minocycline—SLC22A6—brain—germ cell cancer	0.000589	0.00153	CbGeAlD
Minocycline—MMP9—Developmental Biology—KLF4—germ cell cancer	0.000585	0.00215	CbGpPWpGaD
Minocycline—VEGFA—Bladder Cancer—HRAS—germ cell cancer	0.000582	0.00215	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000574	0.00212	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—germ cell cancer	0.000564	0.00208	CbGpPWpGaD
Minocycline—SLC22A7—Fluoropyrimidine Activity—TP53—germ cell cancer	0.000561	0.00207	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000559	0.00206	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGF4—germ cell cancer	0.000557	0.00205	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—MYC—germ cell cancer	0.000554	0.00204	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KITLG—germ cell cancer	0.000554	0.00204	CbGpPWpGaD
Minocycline—CASP3—LPA receptor mediated events—HRAS—germ cell cancer	0.000541	0.00199	CbGpPWpGaD
Minocycline—VEGFA—VEGFR2 mediated cell proliferation—HRAS—germ cell cancer	0.000541	0.00199	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—MYC—germ cell cancer	0.000541	0.00199	CbGpPWpGaD
Minocycline—CASP3—DNA Damage Response—TP53—germ cell cancer	0.000539	0.00199	CbGpPWpGaD
Minocycline—MMP9—Plasma membrane estrogen receptor signaling—HRAS—germ cell cancer	0.000536	0.00198	CbGpPWpGaD
Minocycline—CASP3—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000534	0.00197	CbGpPWpGaD
Minocycline—CASP3—p75(NTR)-mediated signaling—TP53—germ cell cancer	0.000533	0.00196	CbGpPWpGaD
Minocycline—VEGFA—SIDS Susceptibility Pathways—AVP—germ cell cancer	0.00053	0.00195	CbGpPWpGaD
Minocycline—CYCS—Apoptosis Modulation and Signaling—TP53—germ cell cancer	0.000529	0.00195	CbGpPWpGaD
Minocycline—ALOX5—brain—germ cell cancer	0.000521	0.00135	CbGeAlD
Minocycline—CASP3—miRNA Regulation of DNA Damage Response—TP53—germ cell cancer	0.000521	0.00192	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC2A3—germ cell cancer	0.000518	0.00191	CbGpPWpGaD
Minocycline—CASP1—Signaling by Interleukins—HRAS—germ cell cancer	0.000516	0.0019	CbGpPWpGaD
Minocycline—CASP1—Immune System—PVRL2—germ cell cancer	0.000513	0.00189	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—germ cell cancer	0.000511	0.00188	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—KLF4—germ cell cancer	0.000507	0.00187	CbGpPWpGaD
Minocycline—ALOX5—lymph node—germ cell cancer	0.000503	0.00131	CbGeAlD
Minocycline—MMP9—Signaling by SCF-KIT—FGFR3—germ cell cancer	0.000503	0.00185	CbGpPWpGaD
Minocycline—IL1B—Folate Metabolism—TP53—germ cell cancer	0.0005	0.00184	CbGpPWpGaD
Minocycline—SLC22A8—head—germ cell cancer	0.000486	0.00126	CbGeAlD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000482	0.00178	CbGpPWpGaD
Minocycline—CASP3—Alzheimers Disease—TP53—germ cell cancer	0.000478	0.00176	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—KIT—germ cell cancer	0.000462	0.0017	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—MYC—germ cell cancer	0.000461	0.0017	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KITLG—germ cell cancer	0.000458	0.00169	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—germ cell cancer	0.000455	0.00168	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—MYC—germ cell cancer	0.000445	0.00164	CbGpPWpGaD
Minocycline—CASP1—Direct p53 effectors—TP53—germ cell cancer	0.000438	0.00161	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—CD9—germ cell cancer	0.000435	0.0016	CbGpPWpGaD
Minocycline—IL1B—Alzheimers Disease—TP53—germ cell cancer	0.000433	0.00159	CbGpPWpGaD
Minocycline—IL1B—Leptin signaling pathway—HRAS—germ cell cancer	0.000431	0.00159	CbGpPWpGaD
Minocycline—CASP3—Apoptosis Modulation and Signaling—TP53—germ cell cancer	0.000427	0.00157	CbGpPWpGaD
Minocycline—VEGFA—Aryl Hydrocarbon Receptor—HRAS—germ cell cancer	0.000425	0.00156	CbGpPWpGaD
Minocycline—CASP3—Spinal Cord Injury—MYC—germ cell cancer	0.000422	0.00156	CbGpPWpGaD
Minocycline—ALOX5—Metabolism of lipids and lipoproteins—CRABP1—germ cell cancer	0.000415	0.00153	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000414	0.00152	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—SOX2—germ cell cancer	0.000412	0.00152	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—FGFR3—germ cell cancer	0.000412	0.00152	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000408	0.0015	CbGpPWpGaD
Minocycline—CASP3—TNF alpha Signaling Pathway—HRAS—germ cell cancer	0.000405	0.00149	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—MYC—germ cell cancer	0.000404	0.00149	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SCNN1A—germ cell cancer	0.000403	0.00148	CbGpPWpGaD
Minocycline—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—germ cell cancer	0.0004	0.00147	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—H2AFZ—germ cell cancer	0.000387	0.00143	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—MYC—germ cell cancer	0.000382	0.00141	CbGpPWpGaD
Minocycline—CASP1—MAPK Signaling Pathway—TP53—germ cell cancer	0.000379	0.0014	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—KIT—germ cell cancer	0.000378	0.00139	CbGpPWpGaD
Minocycline—MMP9—LPA receptor mediated events—HRAS—germ cell cancer	0.000376	0.00138	CbGpPWpGaD
Minocycline—SLC22A11—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000376	0.00138	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000376	0.00138	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC2A3—germ cell cancer	0.000374	0.00138	CbGpPWpGaD
Minocycline—IL1B—TCR Signaling Pathway—HRAS—germ cell cancer	0.000373	0.00137	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.00037	0.00136	CbGpPWpGaD
Minocycline—CYCS—Metabolism—SLC22A3—germ cell cancer	0.000368	0.00136	CbGpPWpGaD
Minocycline—CYCS—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000368	0.00136	CbGpPWpGaD
Minocycline—MMP9—AP-1 transcription factor network—TP53—germ cell cancer	0.000366	0.00135	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—SOX2—germ cell cancer	0.000358	0.00132	CbGpPWpGaD
Minocycline—VEGFA—SHP2 signaling—HRAS—germ cell cancer	0.000353	0.0013	CbGpPWpGaD
Minocycline—SLC22A8—brain—germ cell cancer	0.000352	0.000916	CbGeAlD
Minocycline—CASP3—Spinal Cord Injury—TP53—germ cell cancer	0.000347	0.00128	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000347	0.00128	CbGpPWpGaD
Minocycline—CYCS—Apoptosis—TP53—germ cell cancer	0.000346	0.00127	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—TP53—germ cell cancer	0.000345	0.00127	CbGpPWpGaD
Minocycline—SLC22A7—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000341	0.00126	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—FGFR3—germ cell cancer	0.00034	0.00125	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—TP53—germ cell cancer	0.000337	0.00124	CbGpPWpGaD
Minocycline—MMP9—Validated targets of C-MYC transcriptional activation—TP53—germ cell cancer	0.000332	0.00122	CbGpPWpGaD
Minocycline—IL1B—Senescence and Autophagy in Cancer—HRAS—germ cell cancer	0.00033	0.00121	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGF4—germ cell cancer	0.000324	0.0012	CbGpPWpGaD
Minocycline—IL1B—Signaling by Interleukins—HRAS—germ cell cancer	0.000322	0.00119	CbGpPWpGaD
Minocycline—VEGFA—Oncostatin M Signaling Pathway—HRAS—germ cell cancer	0.000322	0.00119	CbGpPWpGaD
Minocycline—IL1B—Immune System—PVRL2—germ cell cancer	0.000321	0.00118	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—MYC—germ cell cancer	0.000318	0.00117	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000316	0.00116	CbGpPWpGaD
Minocycline—IL1B—Spinal Cord Injury—TP53—germ cell cancer	0.000314	0.00116	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—KIT—germ cell cancer	0.000312	0.00115	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000311	0.00115	CbGpPWpGaD
Minocycline—CYCS—Metabolism—CRABP1—germ cell cancer	0.0003	0.00111	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—MYC—germ cell cancer	0.000293	0.00108	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—MYC—germ cell cancer	0.000288	0.00106	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000287	0.00106	CbGpPWpGaD
Minocycline—SLC22A8—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000286	0.00106	CbGpPWpGaD
Minocycline—CASP3—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000285	0.00105	CbGpPWpGaD
Minocycline—CASP3—BDNF signaling pathway—HRAS—germ cell cancer	0.000283	0.00104	CbGpPWpGaD
Minocycline—CASP3—Apoptosis—TP53—germ cell cancer	0.000279	0.00103	CbGpPWpGaD
Minocycline—MMP9—EPH-Ephrin signaling—HRAS—germ cell cancer	0.000276	0.00102	CbGpPWpGaD
Minocycline—CASP1—Immune System—KITLG—germ cell cancer	0.000266	0.000982	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC2A3—germ cell cancer	0.000263	0.000971	CbGpPWpGaD
Minocycline—CASP3—MAPK Signaling Pathway—TP53—germ cell cancer	0.000261	0.000963	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—SLC22A3—germ cell cancer	0.000259	0.000956	CbGpPWpGaD
Minocycline—MMP9—Spinal Cord Injury—TP53—germ cell cancer	0.000241	0.000887	CbGpPWpGaD
Minocycline—CASP1—Cytokine Signaling in Immune system—HRAS—germ cell cancer	0.000241	0.000887	CbGpPWpGaD
Minocycline—VEGFA—EPH-Ephrin signaling—HRAS—germ cell cancer	0.00024	0.000883	CbGpPWpGaD
Minocycline—SLC22A6—SLC-mediated transmembrane transport—AVP—germ cell cancer	0.000239	0.000881	CbGpPWpGaD
Minocycline—IL1B—MAPK Signaling Pathway—TP53—germ cell cancer	0.000237	0.000872	CbGpPWpGaD
Minocycline—CASP3—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000236	0.000869	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC2A3—germ cell cancer	0.00023	0.000849	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—SLC22A3—germ cell cancer	0.000227	0.000836	CbGpPWpGaD
Minocycline—CYCS—Cellular responses to stress—TP53—germ cell cancer	0.000226	0.000832	CbGpPWpGaD
Minocycline—VEGFA—VEGFA-VEGFR2 Pathway—HRAS—germ cell cancer	0.000216	0.000797	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—MYC—germ cell cancer	0.000209	0.00077	CbGpPWpGaD
Minocycline—VEGFA—Signaling by VEGF—HRAS—germ cell cancer	0.000204	0.000752	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGF4—germ cell cancer	0.000203	0.000747	CbGpPWpGaD
Minocycline—MMP9—Signaling by SCF-KIT—HRAS—germ cell cancer	0.0002	0.000736	CbGpPWpGaD
Minocycline—CASP1—Immune System—FGFR3—germ cell cancer	0.000198	0.00073	CbGpPWpGaD
Minocycline—SLC22A11—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000191	0.000703	CbGpPWpGaD
Minocycline—ALOX5—Metabolism—CRABP1—germ cell cancer	0.000185	0.000681	CbGpPWpGaD
Minocycline—CASP1—Immune System—KIT—germ cell cancer	0.000182	0.00067	CbGpPWpGaD
Minocycline—SLC22A7—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000173	0.000638	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—MYC—germ cell cancer	0.000173	0.000638	CbGpPWpGaD
Minocycline—VEGFA—Integrated Breast Cancer Pathway—TP53—germ cell cancer	0.000172	0.000632	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—OXT—germ cell cancer	0.00017	0.000625	CbGpPWpGaD
Minocycline—IL1B—Immune System—KITLG—germ cell cancer	0.000167	0.000614	CbGpPWpGaD
Minocycline—CASP3—Signaling by NGF—HRAS—germ cell cancer	0.000163	0.000602	CbGpPWpGaD
Minocycline—IL1B—Cytokine Signaling in Immune system—HRAS—germ cell cancer	0.00015	0.000554	CbGpPWpGaD
Minocycline—SLC22A8—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000146	0.000536	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGF4—germ cell cancer	0.000145	0.000534	CbGpPWpGaD
Minocycline—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—germ cell cancer	0.000142	0.000524	CbGpPWpGaD
Minocycline—VEGFA—Focal Adhesion—HRAS—germ cell cancer	0.000137	0.000503	CbGpPWpGaD
Minocycline—CASP1—Innate Immune System—HRAS—germ cell cancer	0.000135	0.000497	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—H2AFZ—germ cell cancer	0.000129	0.000477	CbGpPWpGaD
Minocycline—IL1B—Immune System—FGFR3—germ cell cancer	0.000124	0.000456	CbGpPWpGaD
Minocycline—SLC22A6—Transmembrane transport of small molecules—AVP—germ cell cancer	0.000121	0.000448	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KITLG—germ cell cancer	0.000119	0.000438	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—OXT—germ cell cancer	0.000118	0.000434	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—AVP—germ cell cancer	0.000116	0.000429	CbGpPWpGaD
Minocycline—IL1B—Immune System—KIT—germ cell cancer	0.000114	0.000419	CbGpPWpGaD
Minocycline—VEGFA—Cellular responses to stress—TP53—germ cell cancer	0.00011	0.000404	CbGpPWpGaD
Minocycline—MMP9—Axon guidance—HRAS—germ cell cancer	0.000103	0.000378	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—OXT—germ cell cancer	0.000102	0.000377	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGF4—germ cell cancer	0.000101	0.00037	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—H2AFZ—germ cell cancer	8.98e-05	0.000331	CbGpPWpGaD
Minocycline—VEGFA—Axon guidance—HRAS—germ cell cancer	8.91e-05	0.000328	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—FGFR3—germ cell cancer	8.84e-05	0.000326	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGF4—germ cell cancer	8.73e-05	0.000322	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KITLG—germ cell cancer	8.26e-05	0.000304	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—KIT—germ cell cancer	8.12e-05	0.000299	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—AVP—germ cell cancer	8.07e-05	0.000297	CbGpPWpGaD
Minocycline—CASP1—Immune System—HRAS—germ cell cancer	7.86e-05	0.00029	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—H2AFZ—germ cell cancer	7.79e-05	0.000287	CbGpPWpGaD
Minocycline—MMP9—Developmental Biology—HRAS—germ cell cancer	7.32e-05	0.00027	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KITLG—germ cell cancer	7.17e-05	0.000264	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—AVP—germ cell cancer	7.01e-05	0.000258	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—TP53—germ cell cancer	6.52e-05	0.00024	CbGpPWpGaD
Minocycline—VEGFA—Developmental Biology—HRAS—germ cell cancer	6.36e-05	0.000234	CbGpPWpGaD
Minocycline—VEGFA—Hemostasis—HRAS—germ cell cancer	6.24e-05	0.00023	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—FGFR3—germ cell cancer	6.14e-05	0.000226	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—KIT—germ cell cancer	5.64e-05	0.000208	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—FGFR3—germ cell cancer	5.33e-05	0.000196	CbGpPWpGaD
Minocycline—IL1B—Immune System—HRAS—germ cell cancer	4.91e-05	0.000181	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—KIT—germ cell cancer	4.89e-05	0.00018	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—MYC—germ cell cancer	4.47e-05	0.000165	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—TP53—germ cell cancer	3.67e-05	0.000135	CbGpPWpGaD
Minocycline—CASP3—Signaling Pathways—HRAS—germ cell cancer	3.51e-05	0.000129	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—MYC—germ cell cancer	3.1e-05	0.000114	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—MYC—germ cell cancer	2.69e-05	9.92e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—TP53—germ cell cancer	2.55e-05	9.38e-05	CbGpPWpGaD
Minocycline—MMP9—Signaling Pathways—HRAS—germ cell cancer	2.44e-05	8.98e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—TP53—germ cell cancer	2.21e-05	8.15e-05	CbGpPWpGaD
Minocycline—VEGFA—Signaling Pathways—HRAS—germ cell cancer	2.11e-05	7.79e-05	CbGpPWpGaD
